130 related articles for article (PubMed ID: 17111262)
1. Aspirin may be more effective in preventing colorectal adenomas in patients with higher BMI (United States).
Kim S; Baron JA; Mott LA; Burke CA; Church TR; McKeown-Eyssen GE; Cole BF; Haile RW; Sandler RS
Cancer Causes Control; 2006 Dec; 17(10):1299-304. PubMed ID: 17111262
[TBL] [Abstract][Full Text] [Related]
2. Do factors related to endogenous and exogenous estrogens modify the relationship between obesity and risk of colorectal adenomas in women?
Wolf LA; Terry PD; Potter JD; Bostick RM
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):676-83. PubMed ID: 17416757
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial of aspirin to prevent colorectal adenomas.
Baron JA; Cole BF; Sandler RS; Haile RW; Ahnen D; Bresalier R; McKeown-Eyssen G; Summers RW; Rothstein R; Burke CA; Snover DC; Church TR; Allen JI; Beach M; Beck GJ; Bond JH; Byers T; Greenberg ER; Mandel JS; Marcon N; Mott LA; Pearson L; Saibil F; van Stolk RU
N Engl J Med; 2003 Mar; 348(10):891-9. PubMed ID: 12621133
[TBL] [Abstract][Full Text] [Related]
4. Aspirin and folic acid for the prevention of recurrent colorectal adenomas.
Logan RF; Grainge MJ; Shepherd VC; Armitage NC; Muir KR;
Gastroenterology; 2008 Jan; 134(1):29-38. PubMed ID: 18022173
[TBL] [Abstract][Full Text] [Related]
5. A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas.
Baron JA; Sandler RS; Bresalier RS; Quan H; Riddell R; Lanas A; Bolognese JA; Oxenius B; Horgan K; Loftus S; Morton DG;
Gastroenterology; 2006 Dec; 131(6):1674-82. PubMed ID: 17087947
[TBL] [Abstract][Full Text] [Related]
6. Association of obesity, serum glucose and lipids with the risk of advanced colorectal adenoma and cancer: a case-control study in Korea.
Chung YW; Han DS; Park YK; Son BK; Paik CH; Lee HL; Jeon YC; Sohn JH
Dig Liver Dis; 2006 Sep; 38(9):668-72. PubMed ID: 16790371
[TBL] [Abstract][Full Text] [Related]
7. Recurrent adenomatous polyps and body mass index.
Davidow AL; Neugut AI; Jacobson JS; Ahsan H; Garbowski GC; Forde KA; Treat MR; Waye JD
Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):313-5. PubMed ID: 8722224
[TBL] [Abstract][Full Text] [Related]
8. Relationship of visceral adipose tissue to recurrence of adenomatous polyps.
Sass DA; Schoen RE; Weissfeld JL; Weissfeld L; Thaete FL; Kuller LH; McAdams M; Lanza E; Schatzkin A
Am J Gastroenterol; 2004 Apr; 99(4):687-93. PubMed ID: 15089903
[TBL] [Abstract][Full Text] [Related]
9. The polyp prevention trial continued follow-up study: no effect of a low-fat, high-fiber, high-fruit, and -vegetable diet on adenoma recurrence eight years after randomization.
Lanza E; Yu B; Murphy G; Albert PS; Caan B; Marshall JR; Lance P; Paskett ED; Weissfeld J; Slattery M; Burt R; Iber F; Shike M; Kikendall JW; Brewer BK; Schatzkin A;
Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1745-52. PubMed ID: 17855692
[TBL] [Abstract][Full Text] [Related]
10. Aspirin and other non-steroidal anti-inflammatory drugs and risk of colorectal cancer: a Danish cohort study.
Friis S; Poulsen AH; Sørensen HT; Tjønneland A; Overvad K; Vogel U; McLaughlin JK; Blot WJ; Olsen JH
Cancer Causes Control; 2009 Jul; 20(5):731-40. PubMed ID: 19122977
[TBL] [Abstract][Full Text] [Related]
11. Peptic ulcer and bleeding events associated with rofecoxib in a 3-year colorectal adenoma chemoprevention trial.
Lanas A; Baron JA; Sandler RS; Horgan K; Bolognese J; Oxenius B; Quan H; Watson D; Cook TJ; Schoen R; Burke C; Loftus S; Niv Y; Ridell R; Morton D; Bresalier R
Gastroenterology; 2007 Feb; 132(2):490-7. PubMed ID: 17258718
[TBL] [Abstract][Full Text] [Related]
12. Does physical activity modify the association between body mass index and colorectal adenomas?
Guilera M; Connelly-Frost A; Keku TO; Martin CF; Galanko J; Sandler RS
Nutr Cancer; 2005; 51(2):140-5. PubMed ID: 15860435
[TBL] [Abstract][Full Text] [Related]
13. [Aspirin in the prevention of colorectal cancer].
Zubiaurre L; Bujanda Fernández de Pierola L
Gastroenterol Hepatol; 2011 May; 34(5):337-45. PubMed ID: 21435744
[TBL] [Abstract][Full Text] [Related]
14. Body Composition and Aspirin Dose for Colorectal Adenoma Prevention in a Randomized Clinical Trial.
Passarelli MN; Barry EL; Rees JR; Mott LA; Ahnen DJ; Baron JA
Cancer Epidemiol Biomarkers Prev; 2019 Jul; 28(7):1262-1265. PubMed ID: 31263057
[TBL] [Abstract][Full Text] [Related]
15. Interaction of calcium supplementation and nonsteroidal anti-inflammatory drugs and the risk of colorectal adenomas.
Grau MV; Baron JA; Barry EL; Sandler RS; Haile RW; Mandel JS; Cole BF
Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2353-8. PubMed ID: 16214916
[TBL] [Abstract][Full Text] [Related]
16. Cholecystectomy and the risk of recurrent colorectal adenomas.
Vinikoor LC; Robertson DJ; Baron JA; Silverman WB; Sandler RS
Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1523-5. PubMed ID: 17627020
[TBL] [Abstract][Full Text] [Related]
17. Meat intake, preparation methods, mutagens and colorectal adenoma recurrence.
Martínez ME; Jacobs ET; Ashbeck EL; Sinha R; Lance P; Alberts DS; Thompson PA
Carcinogenesis; 2007 Sep; 28(9):2019-27. PubMed ID: 17690112
[TBL] [Abstract][Full Text] [Related]
18. Relation between obesity and adenomatous polyps of the large bowel.
Sato Y; Nozaki R; Yamada K; Takano M; Haruma K
Dig Endosc; 2009 Jul; 21(3):154-7. PubMed ID: 19691761
[TBL] [Abstract][Full Text] [Related]
19. Effect of aspirin on prostaglandin E2 formation and transforming growth factor alpha expression in human rectal mucosa from individuals with a history of adenomatous polyps of the colon.
Barnes CJ; Hamby-Mason RL; Hardman WE; Cameron IL; Speeg KV; Lee M
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):311-5. PubMed ID: 10207634
[TBL] [Abstract][Full Text] [Related]
20. Prevention by daily soluble aspirin of colorectal adenoma recurrence: 4-year results of the APACC randomised trial.
Benamouzig R; Uzzan B; Deyra J; Martin A; Girard B; Little J; Chaussade S;
Gut; 2012 Feb; 61(2):255-61. PubMed ID: 21890814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]